SIV's natural hosts reveal how humans might better manage HIV infection

March 8, 2012

Some monkeys can survive infection by SIV, a relative of HIV, and not develop AIDS. Their immune systems appear to display a pattern of "peaceful coexistence" rather than the all-out conflict provoked by HIV when it infects humans.

SIV's natural hosts are non-human primates found in , including sooty mangabeys and African green monkeys – both species whose infections have been studied in captivity -- as well as other species such as mandrills, drills and suntailed monkeys.

Since SIV's natural hosts have adapted to manage infection rather than fight and lose, we have much to learn from them, a team of scientists from Yerkes National Primate Research Center propose in an article published this week in Science.

Studying how SIV and its natural hosts co-exist could show medical researchers how to improve long-term care for people infected with and reduce mother-to-infant transmission, as well as guide the development of an AIDS vaccine, the researchers write.

The authors include Ann Chahroudi, Steven Bosinger, Thomas Vanderford, Mirko Paiardini and Guido Silvestri. Silvestri is chief of microbiology and immunology at Yerkes and a Georgia Research Alliance Eminent Scholar.

Together with NIH researcher Nichole Klatt, Silvestri is also author of a recent Perspective piece in Science Translational Medicine about the role of CD4+ T cells in HIV infection.

In their review, the scientists call SIV's natural hosts "the door through which HIV came to humans." Genetic analysis has shown that HIV infection of humans arose through multiple cross-species transmissions of SIV from non-human primates.

Distinctive features of SIV natural host infection include a low level of immune activation and a low rate of mother-to-infant transmission, compared to humans. This reflects evolutionary history during the last several thousand years, the authors propose.

"In this view, the genetic features of natural SIV hosts that underlie two key mechanisms of resistance (i.e. low immune activation and target cell restriction) may at least partially reflect evolutionary selection to protect from mother-to-infant transmission," they write.

Researchers have observed that a small number of HIV-infected people exhibit a "natural host-like" phenotype, where low levels of immune activation are seen. In most humans, HIV infection leads to chronic immune activation, which causes health problems even in people who receive long-term antiretroviral treatment.

During infection, SIV's natural hosts also manage to preserve particular types of immune cells including Th17 cells, which help maintain the intestines, and central memory T cells, important for keeping the immune system's ability to respond to previously encountered bacteria or viruses.

Understanding how SIV's natural hosts avoid chronic and preserve immune function could help improve medical care for people living with HIV , the authors conclude.

Explore further: Monkeys resist infection by closing gates that SIV, HIV use to get into cells

Related Stories

Recommended for you

Children could point the way to new HIV treatments

September 29, 2016

Children with HIV who can resist the disease progressing could point the way to new treatments for HIV infection that are more widely applicable to infected adults and children alike, an international team of researchers ...

Broadly neutralizing HIV antibodies pave the way for vaccine

September 26, 2016

A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. ...

Targeting dormant HIV

September 19, 2016

Discovery of a novel, advanced technique to identify the rare cells where human immunodeficiency virus (HIV) hides in patients taking antiretroviral therapy (ART). This is an important step forward in the search for a HIV/AIDS ...

Training human antibodies to protect against HIV

September 8, 2016

During HIV infection, the virus mutates too rapidly for the immune system to combat, but some people produce antibodies that can recognize the virus even two years after infection. With an eye towards developing a vaccine, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.